Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

The Biology Behind

  • The Biology Behind
    Multiple Etiologies of Tumor Hypoxia Require Multifaceted Solutions
    Mark W. Dewhirst, Isabel Cardenas Navia, David M. Brizel, Christopher Willett and Timothy W. Secomb
    Clin Cancer Res January 15 2007 13 (2) 375-377; DOI:10.1158/1078-0432.CCR-06-2629

Molecular Pathways

  • Molecular Pathways
    PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors
    Ingo K. Mellinghoff, Tim F. Cloughesy and Paul S. Mischel
    Clin Cancer Res January 15 2007 13 (2) 378-381; DOI:10.1158/1078-0432.CCR-06-1992

Human Cancer Biology

  • Human Cancer Biology
    Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric Cancer
    Tomohiro Osaki, Hiroaki Saito, Toshiaki Yoshikawa, Sachiko Matsumoto, Shigeru Tatebe, Shunichi Tsujitani and Masahide Ikeguchi
    Clin Cancer Res January 15 2007 13 (2) 382-387; DOI:10.1158/1078-0432.CCR-06-1454

  • Human Cancer Biology
    CD8+ T-Cell Content in Diagnostic Lymph Nodes Measured by Flow Cytometry Is a Predictor of Survival in Follicular Lymphoma
    Björn Engelbrekt Wahlin, Birgitta Sander, Birger Christensson and Eva Kimby
    Clin Cancer Res January 15 2007 13 (2) 388-397; DOI:10.1158/1078-0432.CCR-06-1734

  • Human Cancer Biology
    Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
    Pascale Lévy, Hugues Ripoche, Ingrid Laurendeau, Vladimir Lazar, Nicolas Ortonne, Béatrice Parfait, Karen Leroy, Janine Wechsler, Isabelle Salmon, Pierre Wolkenstein, Philippe Dessen, Michel Vidaud, Dominique Vidaud and Ivan Bièche
    Clin Cancer Res January 15 2007 13 (2) 398-407; DOI:10.1158/1078-0432.CCR-06-0182

  • Human Cancer Biology
    Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women
    Naomi Maruyama, Yasuo Miyoshi, Tetsuya Taguchi, Yasuhiro Tamaki, Morito Monden and Shinzaburo Noguchi
    Clin Cancer Res January 15 2007 13 (2) 408-414; DOI:10.1158/1078-0432.CCR-06-0267

  • Human Cancer Biology
    Gene Expression Signature and the Prediction of Ulcerative Colitis–Associated Colorectal Cancer by DNA Microarray
    Toshiaki Watanabe, Takashi Kobunai, Etsuko Toda, Takamitsu Kanazawa, Yoshihiro Kazama, Junichiro Tanaka, Toshiaki Tanaka, Yoko Yamamoto, Keisuke Hata, Tetsu Kojima, Tadashi Yokoyama, Tsuyoshi Konishi, Yoshihiro Okayama, Yoshikazu Sugimoto, Toshinori Oka, Shin Sasaki, Yohichi Ajioka, Tetsuichiro Muto and Hirokazu Nagawa
    Clin Cancer Res January 15 2007 13 (2) 415-420; DOI:10.1158/1078-0432.CCR-06-0753

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
    Niven Mehra, Maarten Penning, Jolanda Maas, Nancy van Daal, Rachel H. Giles and Emile E. Voest
    Clin Cancer Res January 15 2007 13 (2) 421-426; DOI:10.1158/1078-0432.CCR-06-1087

  • Imaging, Diagnosis, Prognosis
    Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Predicts Tumor Differentiation, P-glycoprotein Expression, and Outcome after Resection in Hepatocellular Carcinoma
    Satoru Seo, Etsuro Hatano, Tatsuya Higashi, Tadashi Hara, Masaharu Tada, Nobuyuki Tamaki, Keiko Iwaisako, Iwao Ikai and Shinji Uemoto
    Clin Cancer Res January 15 2007 13 (2) 427-433; DOI:10.1158/1078-0432.CCR-06-1357

  • Imaging, Diagnosis, Prognosis
    Increased Expression of Insulin-like Growth Factor-II Messenger RNA–Binding Protein 1 Is Associated with Tumor Progression in Patients with Lung Cancer
    Tatsuya Kato, Satoshi Hayama, Takumi Yamabuki, Nobuhisa Ishikawa, Masaki Miyamoto, Tomoo Ito, Eiju Tsuchiya, Satoshi Kondo, Yusuke Nakamura and Yataro Daigo
    Clin Cancer Res January 15 2007 13 (2) 434-442; DOI:10.1158/1078-0432.CCR-06-1297

  • Imaging, Diagnosis, Prognosis
    Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy
    Kuei C. Lee, Bradford A. Moffat, Anne F. Schott, Rachel Layman, Steven Ellingworth, Rebecca Juliar, Amjad P. Khan, Mark Helvie, Charles R. Meyer, Thomas L. Chenevert, Alnawaz Rehemtulla and Brian D. Ross
    Clin Cancer Res January 15 2007 13 (2) 443-450; DOI:10.1158/1078-0432.CCR-06-1888

  • Imaging, Diagnosis, Prognosis
    Prognostic Role of the Reduced Folate Carrier, the Major Membrane Transporter for Methotrexate, in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
    Yubin Ge, Christina L. Haska, Katherine LaFiura, Meenakshi Devidas, Stephen B. Linda, Mingjun Liu, Ronald Thomas, Jeffrey W. Taub and Larry H. Matherly
    Clin Cancer Res January 15 2007 13 (2) 451-457; DOI:10.1158/1078-0432.CCR-06-2145

  • Imaging, Diagnosis, Prognosis
    An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
    Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, Lisa M. Sapinoso, Keith Ching, Henry Frierson Jr., Karen Bräutigam, Jalid Sehouli, Elmar Stickeler, Dominique Könsgen, Felix Hilpert, Constantin S. von Kaisenberg, Jacobus Pfisterer, Thomas Bauknecht, Walter Jonat, Norbert Arnold and Garret M. Hampton
    Clin Cancer Res January 15 2007 13 (2) 458-466; DOI:10.1158/1078-0432.CCR-06-0691

  • Imaging, Diagnosis, Prognosis
    BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions in In situ Versus Invasive Cancer
    Ern Yu Tan, Leticia Campo, Cheng Han, Helen Turley, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris and Stephen B. Fox
    Clin Cancer Res January 15 2007 13 (2) 467-474; DOI:10.1158/1078-0432.CCR-06-1466

  • Imaging, Diagnosis, Prognosis
    Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma
    Jens Hillengass, Klaus Wasser, Stefan Delorme, Fabian Kiessling, Christian Zechmann, Axel Benner, Hans-Ulrich Kauczor, Anthony D. Ho, Hartmut Goldschmidt and Thomas M. Moehler
    Clin Cancer Res January 15 2007 13 (2) 475-481; DOI:10.1158/1078-0432.CCR-06-0061

  • Imaging, Diagnosis, Prognosis
    Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer
    Ruiyun Li, Nevins W. Todd, Qi Qiu, Tao Fan, Richard Y. Zhao, William H. Rodgers, Hong-Bin Fang, Ruth L. Katz, Sanford A. Stass and Feng Jiang
    Clin Cancer Res January 15 2007 13 (2) 482-487; DOI:10.1158/1078-0432.CCR-06-1593

  • Imaging, Diagnosis, Prognosis
    Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
    Raihanatou Diallo-Danebrock, Evelyn Ting, Oleg Gluz, Alexander Herr, Svjetlana Mohrmann, Helene Geddert, Achim Rody, Karl-Ludwig Schaefer, Stephan E. Baldus, Arndt Hartmann, Peter J. Wild, Michael Burson, Helmut E. Gabbert, Ulrike Nitz and Christopher Poremba
    Clin Cancer Res January 15 2007 13 (2) 488-497; DOI:10.1158/1078-0432.CCR-06-1842

  • Imaging, Diagnosis, Prognosis
    Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer
    Yu-Hsin Lin, Jan Friederichs, Michael A. Black, Jörg Mages, Robert Rosenberg, Parry J. Guilford, Vicky Phillips, Mark Thompson-Fawcett, Nikola Kasabov, Tumi Toro, Arend E. Merrie, Andre van Rij, Han-Seung Yoon, John L. McCall, Jörg Rüdiger Siewert, Bernhard Holzmann and Anthony E. Reeve
    Clin Cancer Res January 15 2007 13 (2) 498-507; DOI:10.1158/1078-0432.CCR-05-2734

  • Imaging, Diagnosis, Prognosis
    Centromere Protein H Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Overall Patient Survival
    Wen-Ting Liao, Li-Bing Song, Hui-Zhong Zhang, Xing Zhang, Ling Zhang, Wan-Li Liu, Yan Feng, Bao-Hong Guo, Hai-Qiang Mai, Su-Mei Cao, Man-Zhi Li, Hai-De Qin, Yi-Xin Zeng and Mu-Sheng Zeng
    Clin Cancer Res January 15 2007 13 (2) 508-514; DOI:10.1158/1078-0432.CCR-06-1512

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer
    Tanguy Y. Seiwert, Philip P. Connell, Ann M. Mauer, Philip C. Hoffman, Christopher M. George, Livia Szeto, Ravi Salgia, Katherine E. Posther, Binh Nguyen, Daniel J. Haraf and Everett E. Vokes
    Clin Cancer Res January 15 2007 13 (2) 515-522; DOI:10.1158/1078-0432.CCR-06-1058

  • Cancer Therapy: Clinical
    Phase 1b Dose Escalation Study of Erlotinib in Combination with Infusional 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Advanced Solid Tumors
    Axel-R. Hanauske, Jim Cassidy, Javier Sastre, Claus Bolling, Robert J. Jones, Ashok Rakhit, Scott Fettner, Ulrich Brennscheidt, Andrea Feyereislova and Eduardo Díaz-Rubio
    Clin Cancer Res January 15 2007 13 (2) 523-531; DOI:10.1158/1078-0432.CCR-06-1627

  • Cancer Therapy: Clinical
    A Phase I and Pharmacokinetic Study of Pemetrexed Plus Irinotecan in Patients with Advanced Solid Malignancies
    Eric K. Rowinsky, Muralidhar Beeram, Lisa A. Hammond, Garry Schwartz, Johann De Bono, Baharam Forouzesh, Quincy Chu, Jane E. Latz, Shengyan Hong, William John and Binh Nguyen
    Clin Cancer Res January 15 2007 13 (2) 532-539; DOI:10.1158/1078-0432.CCR-06-1606

  • Cancer Therapy: Clinical
    A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients
    Ryan D. Cassaday, Paul M. Sondel, David M. King, Michael D. Macklin, Jacek Gan, Tom F. Warner, Cindy L. Zuleger, Alan J. Bridges, Heidi G. Schalch, Kyung Mann Kim, Jacquelyn A. Hank, David M. Mahvi and Mark R. Albertini
    Clin Cancer Res January 15 2007 13 (2) 540-549; DOI:10.1158/1078-0432.CCR-06-2039

  • Cancer Therapy: Clinical
    Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer
    Daniele Generali, Stephen B. Fox, Alfredo Berruti, John W. Moore, Maria Pia Brizzi, Nilay Patel, Giovanni Allevi, Simone Bonardi, Sergio Aguggini, Alessandra Bersiga, Leticia Campo, Luigi Dogliotti, Alberto Bottini and Adrian L. Harris
    Clin Cancer Res January 15 2007 13 (2) 550-558; DOI:10.1158/1078-0432.CCR-06-1266

  • Cancer Therapy: Clinical
    Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis
    Haesook T. Kim
    Clin Cancer Res January 15 2007 13 (2) 559-565; DOI:10.1158/1078-0432.CCR-06-1210

  • Cancer Therapy: Clinical
    Antigenic Profiling of Glioma Cells to Generate Allogeneic Vaccines or Dendritic Cell–Based Therapeutics
    Jian Gang Zhang, Junichi Eguchi, Carol A. Kruse, German G. Gomez, Habib Fakhrai, Stephanie Schroter, Wenxue Ma, Neil Hoa, Boris Minev, Christina Delgado, H. Terry Wepsic, Hideho Okada and Martin R. Jadus
    Clin Cancer Res January 15 2007 13 (2) 566-575; DOI:10.1158/1078-0432.CCR-06-1576

  • Cancer Therapy: Clinical
    Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Weekly Paclitaxel in Patients with Solid Tumors
    Neal E. Ready, Alan Lipton, Yali Zhu, Paul Statkevich, Emily Frank, Dolores Curtis and Ronald M. Bukowski
    Clin Cancer Res January 15 2007 13 (2) 576-583; DOI:10.1158/1078-0432.CCR-06-1262

  • Cancer Therapy: Clinical
    Phase I Clinical Trial of STA-4783 in Combination with Paclitaxel in Patients with Refractory Solid Tumors
    Anna Berkenblit, Joseph P. Eder Jr., David P. Ryan, Michael V. Seiden, Noriaki Tatsuta, Matthew L. Sherman, Thomas A. Dahl, Bruce J. Dezube and Jeffrey G. Supko
    Clin Cancer Res January 15 2007 13 (2) 584-590; DOI:10.1158/1078-0432.CCR-06-0964

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo
    Archie N. Tse, Katherine G. Rendahl, Tahir Sheikh, Haider Cheema, Kim Aardalen, Millicent Embry, Sylvia Ma, Edward J. Moler, Zhi Jie Ni, Daniel E. Lopes de Menezes, Barbara Hibner, Thomas G. Gesner and Gary K. Schwartz
    Clin Cancer Res January 15 2007 13 (2) 591-602; DOI:10.1158/1078-0432.CCR-06-1424

  • Cancer Therapy: Preclinical
    Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis
    Karin Knogler, Jürgen Grünberg, Kurt Zimmermann, Susan Cohrs, Michael Honer, Simon Ametamey, Peter Altevogt, Mina Fogel, P. August Schubiger and Ilse Novak-Hofer
    Clin Cancer Res January 15 2007 13 (2) 603-611; DOI:10.1158/1078-0432.CCR-06-1486

  • Cancer Therapy: Preclinical
    Human Glioma Cell Sensitivity to the Sequence-Specific Alkylating Agent Methyl-Lexitropsin
    Michael S. Bobola, Sridhar Varadarajan, Nolan W. Smith, Ryan D. Goff, Douglas D. Kolstoe, A. Blank, Barry Gold and John R. Silber
    Clin Cancer Res January 15 2007 13 (2) 612-620; DOI:10.1158/1078-0432.CCR-06-1127

  • Cancer Therapy: Preclinical
    The Bcl-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect with Dexamethasone and Melphalan
    Suzanne Trudel, A. Keith Stewart, Zhihua Li, Yanjun Shu, Sheng-Ben Liang, Young Trieu, Donna Reece, Josh Paterson, Dingyan Wang and Xiao-Yan Wen
    Clin Cancer Res January 15 2007 13 (2) 621-629; DOI:10.1158/1078-0432.CCR-06-1526

  • Cancer Therapy: Preclinical
    Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption
    Nathalie Crokart, Bénédicte F. Jordan, Christine Baudelet, Gregory O. Cron, Julie Hotton, Kim Radermacher, Vincent Grégoire, Nelson Beghein, Philippe Martinive, Caroline Bouzin, Olivier Feron and Bernard Gallez
    Clin Cancer Res January 15 2007 13 (2) 630-635; DOI:10.1158/1078-0432.CCR-06-0802

  • Cancer Therapy: Preclinical
    Early Detection and Rapid Isolation of Leukemia-Reactive Donor T Cells for Adoptive Transfer Using the IFN-γ Secretion Assay
    Inge Jedema, Pauline Meij, Esther Steeneveld, Mels Hoogendoorn, Bart A. Nijmeijer, Marian van de Meent, Simone A.P. van Luxemburg-Heijs, Roel Willemze and J.H. Frederik Falkenburg
    Clin Cancer Res January 15 2007 13 (2) 636-643; DOI:10.1158/1078-0432.CCR-06-2093

  • Cancer Therapy: Preclinical
    Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration
    Laura Bracci, Federica Moschella, Paola Sestili, Valentina La Sorsa, Mara Valentini, Irene Canini, Sara Baccarini, Sonia Maccari, Carlo Ramoni, Filippo Belardelli and Enrico Proietti
    Clin Cancer Res January 15 2007 13 (2) 644-653; DOI:10.1158/1078-0432.CCR-06-1209

Cancer Prevention

  • Cancer Prevention
    Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers
    Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, Anna Marie Daniels, Giske Ursin, John R. Daniels, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike and Darcy V. Spicer
    Clin Cancer Res January 15 2007 13 (2) 654-658; DOI:10.1158/1078-0432.CCR-06-1902

  • Cancer Prevention
    Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance
    Pierre Lao-Sirieix, Laurence Lovat and Rebecca C. Fitzgerald
    Clin Cancer Res January 15 2007 13 (2) 659-665; DOI:10.1158/1078-0432.CCR-06-1385

Innovations and Challenges in Renal Cancer

  • Innovations and Challenges in Renal Cancer
    Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
    Michael B. Atkins, Marc S. Ernstoff, Robert A. Figlin, Keith T. Flaherty, Daniel J. George, William G. Kaelin Jr., Eugene D. Kwon, Towia A. Libermann, W. Marston Linehan, David F. McDermott, Augusto C. Ochoa, Allan J. Pantuck, Brian I. Rini, Mark A. Rosen, Jeffrey A. Sosman, Vikas P. Sukhatme, Johannes W. Vieweg, Christopher G. Wood and Laura King
    Clin Cancer Res January 15 2007 13 (2) 667s-670s; DOI:10.1158/1078-0432.CCR-06-2231

  • Innovations and Challenges in Renal Cancer
    Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics
    W. Marston Linehan, Peter A. Pinto, Ramaprasad Srinivasan, Maria Merino, Peter Choyke, Lynda Choyke, Jonathan Coleman, Jorge Toro, Gladys Glenn, Cathy Vocke, Bert Zbar, Laura S. Schmidt, Donald Bottaro and Len Neckers
    Clin Cancer Res January 15 2007 13 (2) 671s-679s; DOI:10.1158/1078-0432.CCR-06-1870

  • Innovations and Challenges in Renal Cancer
    The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
    William G. Kaelin Jr.
    Clin Cancer Res January 15 2007 13 (2) 680s-684s; DOI:10.1158/1078-0432.CCR-06-1865

  • Innovations and Challenges in Renal Cancer
    Genomics of Renal Cell Cancer: The Biology Behind and the Therapy Ahead
    Jon Jones and Towia A. Libermann
    Clin Cancer Res January 15 2007 13 (2) 685s-692s; DOI:10.1158/1078-0432.CCR-06-1867

  • Innovations and Challenges in Renal Cancer
    Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Is It Still Imperative in the Era of Targeted Therapy?
    Allan J. Pantuck, Arie S. Belldegrun and Robert A. Figlin
    Clin Cancer Res January 15 2007 13 (2) 693s-696s; DOI:10.1158/1078-0432.CCR-06-1916

  • Innovations and Challenges in Renal Cancer
    Multimodal Approaches in the Management of Locally Advanced and Metastatic Renal Cell Carcinoma: Combining Surgery and Systemic Therapies to Improve Patient Outcome
    Christopher G. Wood
    Clin Cancer Res January 15 2007 13 (2) 697s-702s; DOI:10.1158/1078-0432.CCR-06-2109

  • Innovations and Challenges in Renal Cancer
    Protein Expression Profiles in Renal Cell Carcinoma: Staging, Prognosis, and Patient Selection for Clinical Trials
    John S. Lam, Allan J. Pantuck, Arie S. Belldegrun and Robert A. Figlin
    Clin Cancer Res January 15 2007 13 (2) 703s-708s; DOI:10.1158/1078-0432.CCR-06-1864

  • Innovations and Challenges in Renal Cancer
    Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
    R. Houston Thompson, Haidong Dong and Eugene D. Kwon
    Clin Cancer Res January 15 2007 13 (2) 709s-715s; DOI:10.1158/1078-0432.CCR-06-1868

  • Innovations and Challenges in Renal Cancer
    Update on the Application of Interleukin-2 in the Treatment of Renal Cell Carcinoma
    David F. McDermott
    Clin Cancer Res January 15 2007 13 (2) 716s-720s; DOI:10.1158/1078-0432.CCR-06-1872

  • Innovations and Challenges in Renal Cancer
    Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
    Augusto C. Ochoa, Arnold H. Zea, Claudia Hernandez and Paulo C. Rodriguez
    Clin Cancer Res January 15 2007 13 (2) 721s-726s; DOI:10.1158/1078-0432.CCR-06-2197

  • Innovations and Challenges in Renal Cancer
    Reversal of Tumor-Mediated Immunosuppression
    Johannes Vieweg, Zhen Su, Philipp Dahm and Sergei Kusmartsev
    Clin Cancer Res January 15 2007 13 (2) 727s-732s; DOI:10.1158/1078-0432.CCR-06-1924

  • Innovations and Challenges in Renal Cancer
    Developing a Rational Tumor Vaccine Therapy for Renal Cell Carcinoma: Immune Yin and Yang
    Marc S. Ernstoff, Todd S. Crocenzi, John D. Seigne, Nancy A. Crosby, Bernard F. Cole, Jan L. Fisher, Jill C. Uhlenhake, Diane Mellinger, Cathy Foster, Conrad J. Farnham, Kathleen Mackay, Zbigniew M. Szczepiorkowski, Susan M. Webber, Alan R. Schned, Robert D. Harris, Richard J. Barth Jr., John A. Heaney and Randolph J. Noelle
    Clin Cancer Res January 15 2007 13 (2) 733s-740s; DOI:10.1158/1078-0432.CCR-06-2064

  • Innovations and Challenges in Renal Cancer
    Biological Aspects and Binding Strategies of Vascular Endothelial Growth Factor in Renal Cell Carcinoma
    Brian I. Rini and W.Kimryn Rathmell
    Clin Cancer Res January 15 2007 13 (2) 741s-746s; DOI:10.1158/1078-0432.CCR-06-2110

  • Innovations and Challenges in Renal Cancer
    Sorafenib in Renal Cell Carcinoma
    Keith T. Flaherty
    Clin Cancer Res January 15 2007 13 (2) 747s-752s; DOI:10.1158/1078-0432.CCR-06-2063

  • Innovations and Challenges in Renal Cancer
    Phase 2 Studies of Sunitinib and AG013736 in Patients with Cytokine-Refractory Renal Cell Carcinoma
    Daniel J. George
    Clin Cancer Res January 15 2007 13 (2) 753s-757s; DOI:10.1158/1078-0432.CCR-06-2044

  • Innovations and Challenges in Renal Cancer
    The Role of Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cancer
    Daniel Cho, Sabina Signoretti, Meredith Regan, James W. Mier and Michael B. Atkins
    Clin Cancer Res January 15 2007 13 (2) 758s-763s; DOI:10.1158/1078-0432.CCR-06-1986

  • Innovations and Challenges in Renal Cancer
    Opportunities and Obstacles to Combination Targeted Therapy in Renal Cell Cancer
    Jeffrey A. Sosman, Igor Puzanov and Michael B. Atkins
    Clin Cancer Res January 15 2007 13 (2) 764s-769s; DOI:10.1158/1078-0432.CCR-06-1975

  • Innovations and Challenges in Renal Cancer
    Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessing Tumor Vascularity and Vascular Effects of Targeted Therapies in Renal Cell Carcinoma
    Mark A. Rosen and Mitchell D. Schnall
    Clin Cancer Res January 15 2007 13 (2) 770s-776s; DOI:10.1158/1078-0432.CCR-06-1921

  • Innovations and Challenges in Renal Cancer
    Biomarkers for Monitoring Antiangiogenic Therapy
    Rupal S. Bhatt, Pankaj Seth and Vikas P. Sukhatme
    Clin Cancer Res January 15 2007 13 (2) 777s-780s; DOI:10.1158/1078-0432.CCR-06-1922

Back to top
PreviousNext
Clinical Cancer Research: 13 (2)
January 2007
Volume 13, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
  • Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
  • Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Predicts Tumor Differentiation, P-glycoprotein Expression, and Outcome after Resection in Hepatocellular Carcinoma
  • A Phase I and Pharmacokinetic Study of Pemetrexed Plus Irinotecan in Patients with Advanced Solid Malignancies

Jump to

  • The Biology Behind
  • Molecular Pathways
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Prevention
  • Innovations and Challenges in Renal Cancer
Advertisement
  • Most Cited
  • Most Read
Loading
  • Targeted TNF Potentiates the Efficacy of a Peptide Vaccine
  • WNT/β-catenin–Associated Immune Exclusion across Cancers
  • Alisertib for Neuroendocrine Prostate Cancer
  • Genotyping of HCC in the Clinic
  • Single-Cell RNA Sequencing of Pancreatic Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement